Trial Profile
A single center, double-blind, randomized trial to evaluate the effects of aspirin 325 mg + clopidogrel 75 mg v. aspirin 325 mg + placebo on plasma concentration of C-reactive protein: the CATER trial protocol
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary)
- Indications Coronary artery disease; Embolism and thrombosis
- Focus Pharmacodynamics
- Acronyms CATER
- 11 Dec 2006 New trial record.